These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18630168)

  • 41. Dopamine agonist therapy for Parkinson disease and pathological gambling.
    Imamura A; Uitti RJ; Wszolek ZK
    Parkinsonism Relat Disord; 2006 Dec; 12(8):506-8. PubMed ID: 16723269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impulse control and related disorders in Parkinson's disease: review.
    Lim SY; Evans AH; Miyasaki JM
    Ann N Y Acad Sci; 2008 Oct; 1142():85-107. PubMed ID: 18990123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impulse control and related disorders in Mexican Parkinson's disease patients.
    Rodríguez-Violante M; González-Latapi P; Cervantes-Arriaga A; Camacho-Ordoñez A; Weintraub D
    Parkinsonism Relat Disord; 2014 Aug; 20(8):907-10. PubMed ID: 24935236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathological gambling amongst Parkinson's disease and ALS patients in an online community (PatientsLikeMe.com).
    Wicks P; MacPhee GJ
    Mov Disord; 2009 May; 24(7):1085-8. PubMed ID: 19353722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with the development of impulse compulsive disorders in Parkinson patients.
    Rana AQ; Mansoor W; Hussaini S; Al Mosabbir A; Rahman M; Rahman L
    Int J Neurosci; 2013 Jul; 123(7):503-6. PubMed ID: 23336737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction?
    Ambermoon P; Carter A; Hall W; Dissanayaka N; O'Sullivan J
    Addiction; 2012 Feb; 107(2):241-7. PubMed ID: 21793971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathological gambling in PD: did the devil make me do it?
    Dewey RB
    Neurology; 2010 Nov; 75(19):1668-9. PubMed ID: 20926785
    [No Abstract]   [Full Text] [Related]  

  • 48. Impulse control disorders are associated with multiple psychiatric symptoms in Parkinson's disease.
    Jaakkola E; Kaasinen V; Siri C; Martikainen K; Cilia R; Niemelä S; Joutsa J
    J Parkinsons Dis; 2014; 4(3):507-15. PubMed ID: 25112222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reward pathways in Parkinson's disease: clinical and theoretical implications.
    Torta DM; Castelli L
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):203-13. PubMed ID: 18412844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Compulsive eating and weight gain related to dopamine agonist use.
    Nirenberg MJ; Waters C
    Mov Disord; 2006 Apr; 21(4):524-9. PubMed ID: 16261618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases.
    Shapiro MA; Chang YL; Munson SK; Okun MS; Fernandez HH
    Parkinsonism Relat Disord; 2006 Sep; 12(6):392-5. PubMed ID: 16730214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
    McKeon A; Josephs KA; Klos KJ; Hecksel K; Bower JH; Michael Bostwick J; Eric Ahlskog J
    Parkinsonism Relat Disord; 2007 Dec; 13(8):516-9. PubMed ID: 17544807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypersexuality and pathological gambling in Parkinson's disease: A cross-sectional case-control study.
    de Chazeron I; Llorca PM; Chéreau-Boudet I; Blanc O; Perriot J; Ouchchane L; Ulla M; Debilly B; Derost P; Durif F
    Mov Disord; 2011 Sep; 26(11):2127-30. PubMed ID: 21735482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Parkinson's disease and obsessive-compulsive spectrum].
    López-Moríñigo JD; Ramos-Ríos R; Martínez-Formoso S; Arrojo-Romero M; Ecénarro-Tomé P
    Rev Neurol; 2009 Aug 16-31; 49(4):202-9. PubMed ID: 19621323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depression and impulse control disorders in Parkinson's disease: two sides of the same coin?
    Vriend C; Pattij T; van der Werf YD; Voorn P; Booij J; Rutten S; Berendse HW; van den Heuvel OA
    Neurosci Biobehav Rev; 2014 Jan; 38():60-71. PubMed ID: 24239733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disorders of motivation, sexual conduct, and sleep in Parkinson's disease.
    Aarsland D; Alves G; Larsen JP
    Adv Neurol; 2005; 96():56-64. PubMed ID: 16383212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease.
    Santangelo G; Vitale C; Trojano L; Verde F; Grossi D; Barone P
    Mov Disord; 2009 Apr; 24(6):899-905. PubMed ID: 19205072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine dysregulation syndrome in a patient with restless legs syndrome.
    Leu-Semenescu S; Karroum E; Brion A; Konofal E; Arnulf I
    Sleep Med; 2009 Apr; 10(4):494-6. PubMed ID: 19410183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.